Regis Healthcare Limited (ASX:REG)
Australia · Delayed Price · Currency is AUD 6.05
-0.11 (-1.79%)
At close: Jun 10, 2026
Regis Healthcare Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Regis Healthcare stock has a consensus rating of "Buy" and an average price target of $8.20. The average 1-year stock price forecast is 35.54% higher than the current stock price, while the lowest is $7.40 (+22.31%) and the highest is $9.00 (+48.76%).
Price Target: $8.20 (+35.54%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Regis Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Upgrades $7.50 | Buy | Upgrades | $7.50 | +23.97% | May 25, 2026 |
| Ord Minnett | Ord Minnett | Buy Maintains $8.40 → $8.60 | Buy | Maintains | $8.40 → $8.60 | +42.15% | Apr 30, 2026 |
| Jarden | Jarden | Buy Maintains $8.50 | Buy | Maintains | $8.50 | +40.50% | Apr 23, 2026 |
| Jefferies | Jefferies | Buy Maintains $9.00 | Buy | Maintains | $9.00 | +48.76% | Feb 24, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains $7.90 → $8.50 | Buy | Maintains | $7.90 → $8.50 | +40.50% | Feb 23, 2026 |
Financial Forecast
Revenue This Year
1.39B
from 1.16B
Increased by 19.29%
Revenue Next Year
1.51B
from 1.39B
Increased by 8.79%
EPS This Year
0.18
from 0.17
Increased by 6.28%
EPS Next Year
0.24
from 0.18
Increased by 31.84%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5B | ||
| Avg | 1.4B | ||
| Low | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.0% | ||
| Avg | 19.3% | ||
| Low | 13.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.19 | ||
| Avg | 0.18 | ||
| Low | 0.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.4% | ||
| Avg | 6.3% | ||
| Low | -0.2% |